Home - Products - Others - Other Targets - Succinate/succinate receptor antagonist 1

Succinate/succinate receptor antagonist 1

CAS No. 2361972-29-2

Succinate/succinate receptor antagonist 1( —— )

Catalog No. M36075 CAS No. 2361972-29-2

Succinate/succinate receptor antagonist 1 is a potent succinate receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 50 In Stock
2MG 29 In Stock
5MG 46 In Stock
10MG 79 In Stock
25MG 164 In Stock
50MG 254 In Stock
100MG 375 In Stock
200MG 533 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Succinate/succinate receptor antagonist 1
  • Note
    Research use only, not for human use.
  • Brief Description
    Succinate/succinate receptor antagonist 1 is a potent succinate receptor antagonist.
  • Description
    Succinate/succinate receptor antagonist 1 (compound 7a) is a succinate/succinate receptor antagonist. Succinate/succinate receptor antagonist 1 blocks succinate signaling in gingival tissue. Succinate/succinate receptor antagonist 1 inhibits the activation of succinate receptor 1 (SucnRl) with an IC50 value of 20 μΜ. Succinate/succinate receptor antagonist 1 can be used for the research of periodontal disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2361972-29-2
  • Formula Weight
    277.32
  • Molecular Formula
    C17H15N3O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (90.15 mM; Ultrasonic )
  • SMILES
    CNC(=O)Cc1ccc(cc1)-c1ccc2cccnc2n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. LI, Xin, et al. PERIODONTAL DISEASE THERAPY. WO2019136022. 2020.
molnova catalog
related products
  • Vonlerolizumab

    Vonlerolizumab(MOXR 0916) is a humanized IgG agonistic OX40-specific monoclonal antibody with potential antitumor activity for the study of tumors and immune diseases.

  • 11-O-Galloylbergenin

    11-O-Galloylbergenin shows good antioxidant and antiplasmodial activities, it shows significant analgesic activity at doses of 20 and 40 mg/kg against formalin test in rats, and it exhibits significant anti-inflammatory activity in carrageenan-induced paw edema model at doses of 10, 20 and 30 mg/kg.

  • 5-methoxyflavone

    5-methoxyflavone is a naturally occurring, low molecular weight flavonoids compound that associated with a wide wariety of biological activities.